Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DisCOVEries 2 - An Observational Study to Evaluate the Immunogenicity of mRNA COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

NCT05765578 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05765578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05765578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DisCOVEries 2 - An Observational Study to Evaluate the Immunogenicity of mRNA COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
March 8, 2023
Completion date
June 17, 2024
Enrollment
1,713 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19